TY  - GEN
AU  - Swaminathan,Soumya
AU  - Padmapriyadarsini,Chandrasekaran
AU  - Venkatesan,Perumal
AU  - Narendran,Gopalan
AU  - Ramesh Kumar,Santhanakrishnan
AU  - Iliayas,Sheik
AU  - Menon,Pradeep A
AU  - Selvaraju,Sriram
AU  - Pooranagangadevi,Navaneetha P
AU  - Bhavani,Perumal K
AU  - Ponnuraja,Chinnaiyan
AU  - Dilip,Meenalochani
AU  - Ramachandran,Ranjani
TI  - Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial
SN  - 1537-6591
PY  - 2011///1221
KW  - Adult
KW  - Alkynes
KW  - Anti-HIV Agents
KW  - administration & dosage
KW  - Antiretroviral Therapy, Highly Active
KW  - adverse effects
KW  - Antitubercular Agents
KW  - Benzoxazines
KW  - CD4 Lymphocyte Count
KW  - Cyclopropanes
KW  - Female
KW  - HIV Infections
KW  - complications
KW  - Humans
KW  - India
KW  - Liver Function Tests
KW  - Male
KW  - Middle Aged
KW  - Mycobacterium tuberculosis
KW  - isolation & purification
KW  - Nevirapine
KW  - Sputum
KW  - microbiology
KW  - Treatment Outcome
KW  - Tuberculosis
KW  - Viral Load
N1  - Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/cid/cir447
ER  -